Ruta de navegación
Documentos y multimedia
Allowing for uncertainty due to missing and LOCF imputed outcomes in meta-analysis
Allowing for uncertainty due to missing and LOCF imputed outcomes in meta-analysis
Versión 1.0 Aprobado- Tipo del documento
- EXTERNAL_DOCUMENT
- Extensión
- png
- Tamaño
- 339 KB
- Modificado
- 21/10/22 14:05 por mir mir
- Creado
- 21/10/22 14:05 por mir mir
- Localización
- PUBLIC
- Valoraciones
-
-
Versión 1.0Por mir mir, en 21/10/22 14:05Registro sin cambios
Resumen
The use of the last observation carried forward (LOCF) method for imputing missing outcome data in randomized clinical trials has been much criticized and its shortcomings are well understood. However, only recently have published studies widely started using more appropriate imputation methods. Consequently, meta-analyses often include several studies reporting their results according to LOCF. The results from such meta-analyses are potentially biased and overprecise. We develop methods for estimating summary treatment effects for continuous outcomes in the presence of both missing and LOCF-imputed outcome data. Our target is the treatment effect if complete follow-up was obtained even if some participants drop out from the protocol treatment. We extend a previously developed meta-analysis model, which accounts for the uncertainty due to missing outcome data via an informative missingness parameter. The extended model includes an extra parameter that reflects the level of prior confidence in the appropriateness of the LOCF imputation scheme. Neither parameter can be informed by the data and we resort to expert opinion and sensitivity analysis. We illustrate the methodology using two meta-analyses of pharmacological interventions for depression.
El proyecto COMPAR-EU ha recibido financiación del programa de investigación e innovación Horizont 2020 de la Unión Europea en virtud del acuerdo de subvención nº 754936.
Tenga en cuenta que ésta es la versión beta de la plataforma COMPAR-EU. Ahora incluye los resultados completos para Diabetes y durante todo el verano de 2022 se completarán los resultados para Obesidad, EPOC e Insuficiencia Cardíaca. La plataforma también se ampliará y mejorará en los próximos meses.